trial · primary record
INCA036978
Myeloproliferative Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 218 |
| Primary completion | 2030-05-24 |
| Primary endpoint | Number of participants with Dose Limiting Toxicities (DLT)s in Part 1 |
| Registry ID | NCT07441694 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:27.536Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07441694
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.